Company ProfilePremium

Horizon Therapeutics PLC

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Horizon Therapeutics PLC - Healthcare showcase

Year Founded & Workforce

2008

1,000 Employees

Industry

Healthcare

Services

PEGylated Drugs
H

Horizon Therapeutics PLC Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Horizon Therapeutics PLC Overview

Company Headquarters: Dublin, Ireland

Founded: 2008

Workforce: ~1,000

Company Working: Horizon Therapeutics PLC (Horizon) was formerly knowns as Horizon Pharma PLC. In May 2019 the company changed its name from Horizon Pharma PLC to Horizon Therapeutics PLC. The company believes that the new name reflects its strategy and obligation towards patient care. It is operational in the US, Europe, and other locations worldwide. It has products catering to a wide range of indications such as rheumatology, inflammation, and others. The company has different molecules in the pipeline, which provides it a potential business growth.

Strategy

As Horizon is a biopharma company, its strategies include delivering innovative therapy products to patients, business development, and others. To achieve its strategy of providing innovative therapy products, the company works on various products which are in the pipeline. It is also focused on business development through mergers and acquisitions of strategically essential businesses in the market.

Company Snapshot

$981.1M

Revenue

1,000

Employees

2008

Founded

Dublin, Ireland

Headquarters

SWOT Analysis

Strengths

  • Diverse product portfolio
  • Strong R&D

Weaknesses

  • Limited business outside the US
  • Improper and inefficient financial planning

Opportunities

  • Business expansion in markets outside the US region
  • Mergers and acquisitions of potential businesses

Threats

  • High market competition
  • Stringent regulatory policies

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
May 2017AcquisitionHorizon acquired River Vision, a US-based company that operates in R&D of protein therapies. This acquisition has helped Horizon to expand its products range.

Product Offering

  • Horizon Therapeutics PLC
    • PEGylated Drugs

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 981.1 Mn in 2016 to USD 1,207.6 Mn in 2018.
Horizon Therapeutics PLC — By Business Segment
Series (USD Mn)201620172018
Sales981.11,056.21,207.6
R&D Expenses60.722582.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.